Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 37 studies | 42% ± 19% | |
| pericyte | 13 studies | 31% ± 9% | |
| connective tissue cell | 12 studies | 48% ± 20% | |
| smooth muscle cell | 11 studies | 28% ± 12% | |
| myofibroblast cell | 8 studies | 39% ± 14% | |
| adipocyte | 7 studies | 30% ± 15% | |
| mesothelial cell | 4 studies | 27% ± 17% | |
| glial cell | 3 studies | 21% ± 4% | |
| muscle cell | 3 studies | 18% ± 3% | |
| adventitial cell | 3 studies | 32% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 96% | 8019.74 | 439 / 459 | 93% | 170.53 | 1043 / 1118 |
| lung | 100% | 13946.23 | 576 / 578 | 88% | 113.06 | 1016 / 1155 |
| intestine | 98% | 19041.57 | 945 / 966 | 83% | 94.29 | 440 / 527 |
| bladder | 100% | 15384.57 | 21 / 21 | 72% | 86.38 | 361 / 504 |
| stomach | 84% | 10218.94 | 302 / 359 | 87% | 109.41 | 250 / 286 |
| esophagus | 83% | 13210.08 | 1205 / 1445 | 84% | 131.98 | 154 / 183 |
| uterus | 100% | 44629.48 | 170 / 170 | 64% | 100.72 | 296 / 459 |
| ovary | 100% | 20061.54 | 180 / 180 | 64% | 89.85 | 277 / 430 |
| skin | 85% | 20251.53 | 1544 / 1809 | 60% | 53.57 | 282 / 472 |
| prostate | 100% | 17568.38 | 244 / 245 | 41% | 16.11 | 204 / 502 |
| adrenal gland | 90% | 4696.91 | 231 / 258 | 27% | 17.38 | 63 / 230 |
| pancreas | 13% | 869.77 | 44 / 328 | 93% | 235.12 | 165 / 178 |
| thymus | 75% | 3879.27 | 488 / 653 | 27% | 18.13 | 164 / 605 |
| blood vessel | 100% | 16821.63 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 99% | 11489.95 | 1189 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 97% | 6408.03 | 233 / 241 | 0% | 0 | 0 / 0 |
| heart | 83% | 7279.07 | 714 / 861 | 0% | 0 | 0 / 0 |
| kidney | 38% | 2031.22 | 34 / 89 | 34% | 25.24 | 302 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 71% | 89.33 | 32 / 45 |
| liver | 16% | 836.78 | 36 / 226 | 25% | 16.13 | 103 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 34% | 26.46 | 10 / 29 |
| brain | 2% | 91.14 | 57 / 2642 | 12% | 10.32 | 86 / 705 |
| peripheral blood | 9% | 619.87 | 80 / 929 | 0% | 0 | 0 / 0 |
| muscle | 8% | 331.02 | 63 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 5% | 1.24 | 4 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0035989 | Biological process | tendon development |
| GO_0051128 | Biological process | regulation of cellular component organization |
| GO_0007155 | Biological process | cell adhesion |
| GO_0003007 | Biological process | heart morphogenesis |
| GO_0097435 | Biological process | supramolecular fiber organization |
| GO_0001568 | Biological process | blood vessel development |
| GO_1903225 | Biological process | negative regulation of endodermal cell differentiation |
| GO_0030199 | Biological process | collagen fibril organization |
| GO_0045112 | Biological process | integrin biosynthetic process |
| GO_0043588 | Biological process | skin development |
| GO_0035313 | Biological process | wound healing, spreading of epidermal cells |
| GO_0032964 | Biological process | collagen biosynthetic process |
| GO_0048592 | Biological process | eye morphogenesis |
| GO_0016477 | Biological process | cell migration |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005588 | Cellular component | collagen type V trimer |
| GO_0005604 | Cellular component | basement membrane |
| GO_0008201 | Molecular function | heparin binding |
| GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
| GO_0005178 | Molecular function | integrin binding |
| GO_0048407 | Molecular function | platelet-derived growth factor binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0043394 | Molecular function | proteoglycan binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | COL5A1 |
| Protein name | Collagen alpha-1(V) chain Collagen type V alpha 1 chain Alternative protein COL5A1 Collagen type V alpha 1 Alpha-1 type V collagen |
| Synonyms | |
| Description | FUNCTION: Type V collagen is a member of group I collagen (fibrillar forming collagen). It is a minor connective tissue component of nearly ubiquitous distribution. Type V collagen binds to DNA, heparan sulfate, thrombospondin, heparin, and insulin. |
| Accessions | Q9UML4 P20908 H7BY82 B2ZZ86 ENST00000371820.4 [P20908-2] ENST00000371817.8 [P20908-1] L8E771 ENST00000371820.4 |
